SynthesisActa psychiatrica Scandinavica2026
Pineal Gland Volume, Sleep Quality, and Psychiatric Disorders: A Systematic Review and Meta-Analysis.
Synthesis in Acta psychiatrica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
introductionDisturbances in sleep and circadian rhythms are features of several psychiatric disorders. The pineal gland regulates these rhythms via melatonin, with pineal gland volume (PGV) serving as a structural proxy. We conducted a meta-analysis to synthesize evidence on differences in PGV between patients with psychiatric disorders and healthy controls and the association between PGV and sleep outcomes.
methodSystematic searches of PubMed, Embase, Scopus, and Web of Science were performed (August 2025). Study quality was assessed using the Newcastle-Ottawa Scale. Random-effects meta-analyses using restricted maximum likelihood (REML) estimation were conducted for correlation and group-comparison outcomes. Subgroup analyses were performed by diagnostic category.
resultsFourteen studies compared PGV between psychiatric patients and healthy controls, and seven studies examined associations between PGV and sleep outcomes. PGV was significantly lower in patients with psychiatric disorders compared with healthy controls (1055 patients, 712 controls, Hedges' g = -0.54 [-0.68, -0.41], p < 0.001). Reductions were most pronounced in schizophrenia spectrum disorders (g = -0.63 [-0.81, -0.46], p < 0.001), and were approximately twice the magnitude observed in mood disorders (g = -0.33 [-0.59, -0.06], p = 0.027). The pooled association between larger PGV and better sleep was weak and nonsignificant (47 patients, 713 controls, Z
conclusionAcross psychiatric disorders, PGV is reduced relative to healthy controls, with the largest and most consistent reductions observed in schizophrenia spectrum disorders. In contrast, evidence for an association between PGV and sleep outcomes remains inconclusive. These findings suggest that reduced PGV may represent a trait-like structural alteration linked to psychiatric illness, particularly schizophrenia spectrum disorders, rather than a direct marker of sleep disturbance.
trial registrationPROSPERO: CRD420251138624.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.